Idiopathic Intracranial Hypertension Presenting with Sight Loss in a Young Woman: A Narrative Review of Medical, Weight-Management and Surgical Pathways
DOI:
https://doi.org/10.5281/zenodo.22237005Keywords:
Idiopathic Intracranial Hypertension, Papilloedema, Acetazolamide, Visual Loss, Cerebrospinal Fluid DiversionAbstract
Idiopathic intracranial hypertension threatens sight in a population that is young, usually female, and usually well. The condition
is treatable, the randomised evidence covers only mild visual loss, and the patients at greatest risk of blindness are the ones no
trial has studied.
Objectives: To review the published evidence on management of idiopathic intracranial hypertension: what the randomised
medical evidence establishes, what is known about weight-directed treatment, when surgical intervention is indicated, and where
the evidence does not reach.
Material and Methods: Narrative review of randomised trials, consensus diagnostic criteria, cohort studies, surgical series and
society guidance indexed in PubMed and the major neurology and ophthalmology journals. No new patient data were generated;
every estimate quoted is one published by the original investigators.
Results: The one randomised, double-masked, placebo-controlled trial enrolled 165 participants with mild visual loss, defined as
a perimetric mean deviation between -2 and -7 dB, across 38 North American sites. All received a dietary intervention; those
additionally allocated acetazolamide improved by 1.43 dB in perimetric mean deviation at six months against 0.71 dB with
placebo, with improvements also in papilloedema grade, quality of life and opening pressure. The drug effect was independent of
weight change. Sixty-nine of 86 in the acetazolamide group and 57 of 79 on placebo completed follow-up.
Conclusion: Acetazolamide has randomised support, and the effect is real but modest. Its evidence base excludes exactly the
presentation that prompts urgent referral, since patients with severe or rapidly progressive visual loss were not eligible. For
those patients the pathway is surgical and rests entirely on observational data.
Abbreviations: CSF – Cerebrospinal Fluid, IIH – Idiopathic Intracranial Hypertension, IIHTT – Idiopathic Intracranial
Hypertension Treatment Trial, ONSF – Optic Nerve Sheath Fenestration, PMD – Perimetric Mean Deviation, VSS – Venous
Sinus Stenting.
References
Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. "Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management". J Neurol Neurosurg Psychiatry 87(2016):982-992.
Wall M, George D. "Idiopathic intracranial hypertension: a prospective study of 50 patients". Brain 114(1991):155-180.
Friedman DI, Liu GT, Digre KB. "Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children". Neurology 81(2013):1159-1165.
Smith JL. "Whence pseudotumor cerebri?". J Clin Neuroophthalmol 5(1985):55-56.
Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD, et al. "Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity". Ophthalmology 124(2017):697-700.
Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. "The expanding burden of idiopathic intracranial hypertension". Eye 33(2019):478-485.
Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP, et al. "Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom". JAMA Neurol 76(2019):1088-1098.
Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. "Idiopathic intracranial hypertension: consensus guidelines on management". J Neurol Neurosurg Psychiatry 89(2018):1088-1100.
Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. "European Headache Federation guideline on idiopathic intracranial hypertension". J Headache Pain 19(2018):93.
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, et al. "Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial". JAMA 311(2014):1641-1651.
Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. "The idiopathic intracranial hypertension treatment trial: design considerations and methods". J Neuroophthalmol 34(2014):107-117.
Horton JC. "Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial". JAMA 311(2014):1618-1619.
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. "The idiopathic intracranial hypertension treatment trial: clinical profile at baseline". JAMA Neurol 71(2014):693-701.
Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL. "Visual field outcomes for the idiopathic intracranial hypertension treatment trial". Invest Ophthalmol Vis Sci 57(2016):805-812.
Thambisetty M, Lavin PJ, Newman NJ, Biousse V. "Fulminant idiopathic intracranial hypertension". Neurology 68(2007):229-232.
Thurtell MJ. "Idiopathic intracranial hypertension". Continuum 25(2019):1289-1309.
Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z, et al. "Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial". JAMA Neurol 78(2021):678-686.
Kalyvas A, Neromyliotis E, Koutsarnakis C, Komaitis S, Drosos E, Skandalakis GP, et al. "A systematic review of surgical treatments of idiopathic intracranial hypertension". Neurosurg Rev 44(2021):773-792.
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. "Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study". BMJ 341(2010):c2701.
Subramaniam S, Fletcher WA. "Obesity and weight loss in idiopathic intracranial hypertension: a narrative review". J Neuroophthalmol 37(2017):197-205.
Mollan SP, Hoffmann J, Sinclair AJ. "Advances in the understanding of headache in idiopathic intracranial hypertension". Curr Opin Neurol 32(2019):92-98.
Kleinschmidt JJ, Digre KB, Hanover R. "Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life". Neurology 54(2000):319-324.
Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O'Brien D. "Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts, case series and literature review". Br J Neurosurg 25(2011):94-99.
Banta JT, Farris BK. "Pseudotumor cerebri and optic nerve sheath decompression". Ophthalmology 107(2000):1907-1912.
Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ, et al. "Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions". AJNR Am J Neuroradiol 32(2011):1408-1414.
Satti SR, Leishangthem L, Chaudry MI. "Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension". AJNR Am J Neuroradiol 36(2015):1899-1904.
Nicholson P, Brinjikji W, Radovanovic I, Hilditch CA, Tsang ACO, Krings T, et al. "Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis". J Neurointerv Surg 11(2019):380-385.
Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH. "The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study". Eur J Neurol 21(2014):1458-1464.
Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, et al. "Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial". Headache 57(2017):1195-1205.
Mollan SP, Grech O, Sinclair AJ. "Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review". Headache 61(2021):808-816.
Chan JW. "Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults". J Neurol 264(2017):1622-1633.
Ball AK, Clarke CE. "Idiopathic intracranial hypertension". Lancet Neurol 5(2006):433-442.
Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP. "Interventions for idiopathic intracranial hypertension". Cochrane Database Syst Rev 8(2015):CD003434.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ. "Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions". Lancet Neurol 15(2016):78-91.
Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. "Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review". Cephalalgia 31(2011):1627-1633.
